dGenThera, Inc.
PrivateCompany Overview
dGenThera, Inc. operates in Healthcare & Life Sciences and is based in Durham, North Carolina.
dGenThera, Inc. is a biotechnology company that develops theranostic molecular pairs for the diagnosis and treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
dGenThera, Inc. Comparables
Compare dGenThera, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fuzionaire Theranostics | 89% | |
| Ariceum Therapeutics | 78% | |
| Alpha Fusion Inc. | 77% |
For institutional investors. Book with your work email.
dGenThera, Inc. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
dGenThera, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about dGenThera, Inc.'s valuation, stock price, and market status.
Is dGenThera, Inc. a public or private company?
dGenThera, Inc. is a private company.
What is the current stock price of dGenThera, Inc.?
dGenThera, Inc. is a private company, so its shares have no public market price. Caplight tracks dGenThera, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is dGenThera, Inc. worth (valuation)?
Valuation information for dGenThera, Inc. is not publicly available.
Can I buy dGenThera, Inc. stock?
dGenThera, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was dGenThera, Inc.'s last funding round?
Funding round information for dGenThera, Inc. is not publicly available.
Who are the main investors in dGenThera, Inc.?
Investor information for dGenThera, Inc. is not publicly disclosed.
Will dGenThera, Inc. IPO soon?
No public IPO plans have been announced for dGenThera, Inc..
How can I track dGenThera, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in dGenThera, Inc.'s shares on secondary markets.